Fetal hormonal programming of sex differences in depression: Linking women's mental health with sex differences in the brain across the lifespan

Frontiers in Neuroscience

Volumn , Issue 8 JUL, 2014, Pages

  Goldstein, Jill M ^a,c   Holsen, Laura ^a,b   Handa, Robert ^d   Tobet, Stuar ^e  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^e Engineering Research Center and Hydraulics Laboratory   (United States)

Author keywords

Fetal programming; Major depression; Mood; Sex differences; Stress; Women's health

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; CORTICOTROPIN; ESTRADIOL; HYDROCORTISONE; PROGESTERONE; SOMATOMEDIN;

ARTICLE; BRAIN SIZE; DISEASE ASSOCIATION; FETAL HORMONAL PROGRAMMING; FETUS DEVELOPMENT; GENETIC VARIABILITY; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; MAJOR DEPRESSION; MENTAL HEALTH; MOOD; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; PUBERTY; SEX DIFFERENTIATION; TREATMENT RESPONSE; WOMEN'S HEALTH; BRAIN DEVELOPMENT; CLIMACTERIUM; HEALTH CARE NEED; HYPOPHYSIS FUNCTION; HYPOPHYSIS GONAD SYSTEM; LIFESPAN; NOTE; RISK ASSESSMENT; SEX DIFFERENCE;

EID: 84905917816     PISSN: 16624548     EISSN: 1662453X     Source Type: Journal    
DOI: 10.3389/fnins.2014.00247     Document Type: Article

References (157)

1. Ustun, T.B., et al., Global burden of depressive disorders in the year 2000. British Journal of Psychiatry, 2004. 184: p. 386-92.
2. Kendler, K.S., et al., A Swedish national twin study of lifetime major depression. American Journal of Psychiatry, 2006. 163(1): p. 109-14.
3. Kessler, R.C., Epidemiology of women and depression. Journal of Affective Disorders, 2003. 74: p. 5-13.
4. Board, F., H. Persky, and D.A. Hamburg, Psychological stress and endocrine functions; blood levels of adrenocortical and thyroid hormones in acutely disturbed patients. Psychosomatic Medicine, 1956. 18(4): p. 324-33.
5. Gibbons, J.L. and P.R. Mc Hugh, Plasma cortisol in depressive illness. Journal of Psychiatric Research, 1962. 1: p. 162-71.
6. Barim, A.O., et al., Ghrelin, paraoxonase and arylesterase levels in depressive patients before and after citalopram treatment. Clinical Biochemistry, 2009. 42(10-11): p. 1076-81.
7. Brouwer, J.P., et al., Thyroid and adrenal axis in major depression: a controlled study in outpatients. European Journal of Endocrinology/European Federation of Endocrine Societies, 2005. 152(2): p. 185-91.
8. Coplan, J.D., et al., Nocturnal growth hormone secretion studies in adolescents with or without major depression re-examined: integration of adult clinical follow-up data. Biological Psychiatry, 2000. 47(7): p. 594-604.
9. Kurt, E., et al., The effects of electroconvulsive therapy on ghrelin, leptin and cholesterol levels in patients with mood disorders. Neuroscience Letters, 2007. 426(1): p. 49-53.
10. Plotsky, P.M., M.J. Owens, and C.B. Nemeroff, Psychoneuroendocrinology of depression. Hypothalamic-pituitary-adrenal axis. Psychiatric Clinics of North America, 1998. 21(2): p. 293-307.
11. Swaab, D.F., A.M. Bao, and P.J. Lucassen, The stress system in the human brain in depression and neurodegeneration. Ageing Res Rev, 2005. 4(2): p. 141-94.
12. Young, E.A. and A. Korszun, The hypothalamic-pituitary-gonadal axis in mood disorders. Endocrinology and Metabolism Clinics of North America, 2002. 31(1): p. 63-78.
13. Goldstein, J.M., et al., Sex-specific impact of maternal-fetal risk factors on depression and cardiovascular risk 40 years later. J Dev Orig Health Dis, 2011. 2(6): p. 353-364.
14. McClellan, K.M., M.S. Stratton, and S.A. Tobet, Roles for gamma-aminobutyric acid in the development of the paraventricular nucleus of the hypothalamus. The Journal of Comparative Neurology, 2010. 518(14): p. 2710-28.
15. Carbone, D.L. and R.J. Handa, Sex and stress hormone influences on the expression and activity of brain-derived neurotrophic factor. Neuroscience, 2013. 239: p. 295-303.
16. Seney, M.L., et al., Sex chromosome complement regulates expression of mood-related genes. Biology of Sex Differences, 2013. 4(1): p. 20.
17. Zuloaga, D.G., D.L. Carbone, and R.J. Handa, Prenatal dexamethasone selectively decreases calretinin expression in the adult female lateral amygdala. Neuroscience Letters, 2012.
18. Zuloaga, D.G., et al., Perinatal dexamethasone-induced alterations in apoptosis within the hippocampus and paraventricular nucleus of the hypothalamus are influenced by age and sex. Journal of Neuroscience Research, 2012. 90(7): p. 1403-12.
19. Sonino, N., et al., Clinical correlates of major depression in Cushing's disease. Psychopathology, 1998. 31(6): p. 302-6.
20. Kelly, W.F., S.A. Checkley, and D.A. Bender, Cushing's syndrome, tryptophan and depression. British Journal of Psychiatry, 1980. 136: p. 125-32.
21. Ling, M.H., P.J. Perry, and M.T. Tsuang, Side effects of corticosteroid therapy. Psychiatric aspects. Archives of General Psychiatry, 1981. 38(4): p. 471-7.
22. Banki, C.M., et al., CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia. American Journal of Psychiatry, 1987. 144(7): p. 873-7.
23. Carroll, B.J., G.C. Curtis, and J. Mendels, Cerebrospinal fluid and plasma free cortisol concentrations in depression. Psychological Medicine, 1976. 6(2): p. 235-44.
24. Carroll, B.J., et al., A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility. Archives of General Psychiatry, 1981. 38(1): p. 15-22.
25. Evans, D.L. and C.B. Nemeroff, The clinical use of the dexamethasone suppression test in DSM-III affective disorders: correlation with the severe depressive subtypes of melancholia and psychosis. Journal of Psychiatric Research, 1987. 21(2): p. 185-94.
26. Halbreich, U., et al., Cortisol secretion in endogenous depression. I. Basal plasma levels. Archives of General Psychiatry, 1985. 42(9): p. 904-8.
27. Heim, C., et al., Altered pituitary-adrenal axis responses to provocative challenge tests in adult survivors of childhood abuse. American Journal of Psychiatry, 2001. 158(4): p. 575-81.
28. Holsboer, F., et al., ACTH, cortisol, and corticosterone output after ovine corticotropinreleasing factor challenge during depression and after recovery. Biological Psychiatry, 1985. 20(3): p. 276-86.
29. Jarrett, D.B., P.A. Coble, and D.J. Kupfer, Reduced cortisol latency in depressive illness. Archives of General Psychiatry, 1983. 40(5): p. 506-11.
30. Nemeroff, C.B., et al., Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science, 1984. 226(4680): p. 1342-4.
31. Newport, D.J., et al., Cerebrospinal fluid corticotropin-releasing factor (CRF) and vasopressin concentrations predict pituitary response in the CRF stimulation test: a multiple regression analysis. Neuropsychopharmacology, 2003. 28(3): p. 569-76.
32. Raison, C.L. and A.H. Miller, When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders. American Journal of Psychiatry, 2003. 160(9): p. 1554-65.
33. Rubin, R.T., et al., Neuroendocrine aspects of primary endogenous depression. I. Cortisol secretory dynamics in patients and matched controls. Archives of General Psychiatry, 1987. 44(4): p. 328-36.
34. Bremmer, M.A., et al., Major depression in late life is associated with both hypo- and hypercortisolemia. Biological Psychiatry, 2007. 62(5): p. 479-86.
35. Nelson, W.H., et al., The dexamethasone suppression test: interaction of diagnosis, sex, and age in psychiatric inpatients. Biological Psychiatry, 1984. 19(9): p. 1293-304.
36. Nelson, W.H., et al., Hypothalamic-pituitary-adrenal axis activity and age in major depression. Journal of Clinical Psychiatry, 1984. 45(3): p. 120-1.
37. Poor, V., et al., Urinary steroid metabolites and 11beta-hydroxysteroid dehydrogenase activity in patients with unipolar recurrent major depression. Journal of Affective Disorders, 2004. 81(1): p. 55-9.
38. De Bellis, M.D., et al., Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine vasopressin in patients with major depression. American Journal of Psychiatry, 1993. 150(4): p. 656-7.
39. Nemeroff, C.B., et al., Neuropeptide concentrations in the cerebrospinal fluid of depressed patients treated with electroconvulsive therapy. Corticotrophin-releasing factor, beta-endorphin and somatostatin. British Journal of Psychiatry, 1991. 158: p. 59-63.
40. Veith, R.C., et al., Effect of desipramine on cerebrospinal fluid concentrations of corticotropin-releasing factor in human subjects. Psychiatry Research, 1993. 46(1): p. 1-8.
41. McKay, M.S. and K.K. Zakzanis, The impact of treatment on HPA axis activity in unipolar major depression. Journal of Psychiatric Research, 2010. 44(3): p. 183-92.
42. Vreeburg, S.A., et al., Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study. Archives of General Psychiatry, 2009. 66(6): p. 617-26.
43. Trestman, R.L., et al., The cortisol response to clonidine in acute and remitted depressed men. Biological Psychiatry, 1993. 34(6): p. 373-9.
44. Ahrens, T., et al., Pituitary-adrenal and sympathetic nervous system responses to stress in women remitted from recurrent major depression. Psychosomatic Medicine, 2008. 70(4): p. 461-7.
45. Lok, A., et al., Longitudinal hypothalamic-pituitary-adrenal axis trait and state effects in recurrent depression. Psychoneuroendocrinology, 2012. 37(7): p. 892-902.
46. Vythilingam, M., et al., Hippocampal volume, memory, and cortisol status in major depressive disorder: effects of treatment. Biol Psychiatry, 2004. 56(2): p. 101-12.
47. Appelhof, B.C., et al., Glucocorticoids and relapse of major depression (dexamethasone/corticotropin-releasing hormone test in relation to relapse of major depression). Biological Psychiatry, 2006. 59(8): p. 696-701.
48. Ising, M., et al., Combined dexamethasone/corticotropin releasing hormone test predicts treatment response in major depression-a potential biomarker? Biological Psychiatry, 2007. 62(1): p. 47-54.
49. Zobel, A.W., et al., Prediction of medium-term outcome by cortisol response to the combined dexamethasone-CRH test in patients with remitted depression. American Journal of Psychiatry, 1999. 156(6): p. 949-51.
50. Jahn, H., et al., Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial. Arch Gen Psychiatry, 2004. 61(12): p. 1235-44.
51. Young, A.H., et al., Improvements in neurocognitive function and mood following adjunctive treatment with mifepristone (RU-486) in bipolar disorder. Neuropsychopharmacology, 2004. 29(8): p. 1538-45.
52. Goldstein, J.M., et al., Sex differences in stress response circuitry activation dependent on female hormonal cycle. Journal of Neuroscience, 2010. 30(2): p. 431-8.
53. Kudielka, B.M. and C. Kirschbaum, Sex differences in HPA axis responses to stress: a review. Biological Psychology, 2005. 69(1): p. 113-32.
54. Holsen, L.M., et al., Stress response circuitry hypoactivation related to hormonal dysfunction in women with major depression. Journal of Affective Disorders, 2011. 131(1-3): p. 379-87.
55. Holsen, L.M., et al., HPA-Axis Hormone Modulation of Stress Response Circuitry Activity in Women with Remitted Major Depression. Neuroscience, 2013.
56. Young, E.A., S.C. Ribeiro, and W. Ye, Sex differences in ACTH pulsatility following metyrapone blockade in patients with major depression. Psychoneuroendocrinology, 2007. 32(5): p. 503-7.
57. Hinkelmann, K., et al., Sex differences of salivary cortisol secretion in patients with major depression. Stress, 2011.
58. Chopra, K.K., et al., Sex differences in hormonal responses to a social stressor in chronic major depression. Psychoneuroendocrinology, 2009. 34(8): p. 1235-41.
59. Young, E.A. and M. Altemus, Puberty, ovarian steroids, and stress. Annals of the New York Academy of Sciences, 2004. 1021: p. 124-33.
60. Haefner, S., et al., Impact of gene-gender effects of adrenergic polymorphisms on hypothalamic-pituitary-adrenal axis activity in depressed patients. Neuropsychobiology, 2008. 58(3-4): p. 154-62.
61. Dahl, R., et al., Cortisol secretion in adolescents with major depressive disorder. Acta Psychiatrica Scandinavica, 1989. 80(1): p. 18-26.
62. Deuschle, M., et al., Effects of major depression, aging and gender upon calculated diurnal free plasma cortisol concentrations: a re-evaluation study. Stress, 1998. 2(4): p. 281-7.
63. Maes, M., J. Calabrese, and H.Y. Meltzer, The relevance of the in- versus outpatient status for studies on HPA-axis in depression: spontaneous hypercortisolism is a feature of major depressed inpatients and not of major depression per se. Progress in Neuro- Psychopharmacology and Biological Psychiatry, 1994. 18(3): p. 503-17.
64. Kirschbaum, C., et al., Impact of gender, menstrual cycle phase, and oral contraceptives on the activity of the hypothalamus-pituitary-adrenal axis. Psychosomatic Medicine, 1999. 61(2): p. 154-62.
65. Hankin, B.L., et al., Development of depression from preadolescence to young adulthood: emerging gender differences in a 10-year longitudinal study. Journal of Abnormal Psychology, 1998. 107(1): p. 128.
66. Schulz, K.M., H.A. Molenda-Figueira, and C.L. Sisk, Back to the future: The organizational-activational hypothesis adapted to puberty and adolescence. Hormones and Behavior, 2009. 55(5): p. 597-604.
67. Himelein, M.J. and S.S. Thatcher, Polycystic ovary syndrome and mental health: A review. Obstetrical and Gynecological Survey, 2006. 61(11): p. 723-32.
68. Angold, A. and E.J. Costello, Puberty and depression. Child Adolesc Psychiatr Clin N Am, 2006. 15(4): p. 919-37, ix.
69. Bloch, M., et al., Effects of gonadal steroids in women with a history of postpartum depression. American Journal of Psychiatry, 2000. 157(6): p. 924-30.
70. Brummelte, S. and L.A. Galea, Depression during pregnancy and postpartum: contribution of stress and ovarian hormones. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2010. 34(5): p. 766-76.
71. Graziottin, A. and A. Serafini, Depression and the menopause: why antidepressants are not enough? Menopause Int, 2009. 15(2): p. 76-81.
72. Payne, J.L., The role of estrogen in mood disorders in women. Int Rev Psychiatry, 2003. 15(3): p. 280-90.
73. Steiner, M., Female-specific mood disorders. Clinical Obstetrics and Gynecology, 1992. 35(3): p. 599-611.
74. Young, E.A., et al., Influences of hormone-based contraception on depressive symptoms in premenopausal women with major depression. Psychoneuroendocrinology, 2007. 32(7): p. 843-53.
75. Schweiger, U., et al., Testosterone, gonadotropin, and cortisol secretion in male patients with major depression. Psychosomatic Medicine, 1999. 61(3): p. 292-6.
76. Seidman, S.N., et al., Testosterone level, androgen receptor polymorphism, and depressive symptoms in middle-aged men. Biological Psychiatry, 2001. 50(5): p. 371-6.
77. Baischer, W., et al., Hypothalamic-pituitary-gonadal axis in depressed premenopausal women: elevated blood testosterone concentrations compared to normal controls. Psychoneuroendocrinology, 1995. 20(5): p. 553-9.
78. Rubinow, D.R. and P.J. Schmidt, Androgens, brain, and behavior. American Journal of Psychiatry, 1996. 153(8): p. 974-84.
79. Weiner, C.L., M. Primeau, and D.A. Ehrmann, Androgens and mood dysfunction in women: comparison of women with polycystic ovarian syndrome to healthy controls. Psychosomatic Medicine, 2004. 66(3): p. 356-62.
80. Young, E.A., et al., Alteration in the hypothalamic-pituitary-ovarian axis in depressed women. Archives of General Psychiatry, 2000. 57: p. 1157-1162.
81. Daly, R.C., et al., Concordant restoration of ovarian function and mood in perimenopausal depression. American Journal of Psychiatry, 2003. 160(10): p. 1842-6.
82. Harlow, B.L., et al., Depression and its influence on reproductive endocrine and menstrual cycle markers associated with perimenopause: the Harvard Study of Moods and Cycles. Archives of General Psychiatry, 2003. 60(1): p. 29-36.
83. Rabin, D.S., et al., Hypothalamic-pituitary-adrenal function in patients with the premenstrual syndrome. Journal of Clinical Endocrinology and Metabolism, 1990. 71(5): p. 1158-62.
84. Roca, C.A., et al., Differential menstrual cycle regulation of hypothalamic-pituitaryadrenal axis in women with premenstrual syndrome and controls. Journal of Clinical Endocrinology and Metabolism, 2003. 88(7): p. 3057-63.
85. Dougherty, D. and S.L. Rauch, Neuroimaging and neurobiological models of depression. Harvard Review of Psychiatry, 1997. 5(3): p. 138-59.
86. Drevets, W.C., et al., Glucose metabolism in the amygdala in depression: relationship to diagnostic subtype and plasma cortisol levels. Pharmacology, Biochemistry and Behavior, 2002. 71(3): p. 431-47.
87. Mayberg, H.S., Limbic-cortical dysregulation: a proposed model of depression. Journal of Neuropsychiatry and Clinical Neurosciences, 1997. 9(3): p. 471-481.
88. Rauch, S.L., L.M. Shin, and C.I. Wright, Neuroimaging studies of amygdala function in anxiety disorders. Annals of the New York Academy of Sciences, 2003. 985: p. 389-410.
89. Sheline, Y.I., B.L. Mittler, and M.A. Mintun, The hippocampus and depression. Eur Psychiatry, 2002. 17 Suppl 3: p. 300-5.
90. Clark, A.S., N.J. MacLusky, and P.S. Goldman-Rakic, Androgen binding and metabolism in the cerebral cortex of the developing rhesus monkey. Endocrinology, 1988. 123(2): p. 932-40.
91. Donahue, J.E., et al., Cells containing immunoreactive estrogen receptor-alpha in the human basal forebrain. Brain Research: Molecular Brain Research, 2000. 856(1-2): p. 142-151.
92. Handa, R.J., et al., Gonadal steroid hormone receptors and sex differences in the hypothalamo-pituitary-adrenal axis. Hormones and Behavior, 1994. 28(4): p. 464-76.
93. Kawata, M., Roles of steroid hormones and their receptors in structural organization in the nervous system. Neuroscience Research, 1995. 24(1): p. 1-46.
94. MacLusky, N.J., et al., Estrogen formation in the mammalian brain: possible role of aromatase in sexual differentiation of the hippocampus and neocortex. Steroids, 1987. 50(4-6): p. 459-74.
95. Östlund, H., E. Keller, and Y.L. Hurd, Estrogen receptor gene expression in relation to neuropsychiatric disorders. Annals of the New York Academy of Sciences, 2003. 1007: p. 54-63.
96. Tobet, S.A. and I.K. Hanna, Ontogeny of sex differences in the mammalian hypothalamus and preoptic area. Cellular and Molecular Neurobiology, 1997. 17(6): p. 565-601.
97. Goldstein, J.M., et al., Sex differences in stress response circuitry activation dependent on female hormonal cycle. The Journal of Neuroscience, 2010. 30(2): p. 431-8.
98. Root, J.C., et al., Frontolimbic function and cortisol reactivity in response to emotional stimuli. Neuroreport, 2009. 20(4): p. 429-34.
99. Pruessner, J.C., et al., Deactivation of the limbic system during acute psychosocial stress: evidence from positron emission tomography and functional magnetic resonance imaging studies. Biological Psychiatry, 2008. 63(2): p. 234-40.
100. Wang, J., et al., Gender difference in neural response to psychological stress. Social Cognitive and Affective Neuroscience, 2007. 2(3): p. 227-39.
101. Stark, R., et al., Influence of the stress hormone cortisol on fear conditioning in humans: evidence for sex differences in the response of the prefrontal cortex. NeuroImage, 2006. 32(3): p. 1290-8.
102. Goldstein, J.M., et al., Hormonal cycle modulates arousal circuitry in women using functional magnetic resonance imaging. Journal of Neuroscience, 2005. 25(40): p. 9309-16.
103. Andreano, J.M. and L. Cahill, Menstrual cycle modulation of medial temporal activity evoked by negative emotion. NeuroImage, 2010. 53(4): p. 1286-93.
104. Protopopescu, X., et al., Orbitofrontal cortex activity related to emotional processing changes across the menstrual cycle. Proceedings of the National Academy of Sciences of the United States of America, 2005. 102(44): p. 16060-5.
105. Amin, Z., et al., Effects of estrogen variation on neural correlates of emotional response inhibition. NeuroImage, 2006. 32(1): p. 457-64.
106. Dreher, J.C., et al., Menstrual cycle phase modulates reward-related neural function in women. Proceedings of the National Academy of Sciences of the United States of America, 2007. 104(7): p. 2465-70.
107. van Wingen, G.A., et al., Progesterone selectively increases amygdala reactivity in women. Molecular Psychiatry, 2008. 13(3): p. 325-33.
108. van Wingen, G., et al., Testosterone biases automatic memory processes in women towards potential mates. NeuroImage, 2008. 43(1): p. 114-20.
109. van Wingen, G.A., et al., Testosterone increases amygdala reactivity in middle-aged women to a young adulthood level. Neuropsychopharmacology, 2009. 34(3): p. 539-47.
110. Filipek, P.A., et al., The young adult human brain: an MRI-based morphometric analysis. Cerebral Cortex, 1994. 4(4): p. 344-60.
111. Giedd, J.N., et al., Quantitative MRI of the temporal lobe, amygdala, and hippocampus in normal human development: ages 4-18 years. Journal of Comparative Neurology, 1996. 366(2): p. 223-30.
112. Goldstein, J.M., et al., Normal sexual dimorphism of the adult human brain assessed by in vivo magnetic resonance imaging. Cerebral Cortex, 2001. 11(6): p. 490-7.
113. Murphy, D.G., et al., Sex differences in human brain morphometry and metabolism: an in vivo quantitative magnetic resonance imaging and positron emission tomography study on the effect of aging. Archives of General Psychiatry, 1996. 53(7): p. 585-94.
114. Paus, T., et al., In vivo morphometry of the intrasulcal gray matter in the human cingulate, paracingulate, and superior-rostral sulci: Hemispheric asymmetries, gender differences and probability maps. Journal of Comparative Neurology, 1996. 376(4): p. 664-73.
115. Allen, L.S., et al., Two sexually dimorphic cell groups in the human brain. Journal of Neuroscience, 1989. 9(2): p. 497-506.
116. Swaab, D.F. and E. Fliers, A sexually dimorphic nucleus in the human brain. Science, 1985. 228(4703): p. 1112-5.
117. Ruigrok, A.N., et al., A meta-analysis of sex differences in human brain structure. Neuroscience & Biobehavioral Reviews, 2013.
118. Ingalhalikar, M., et al., Sex differences in the structural connectome of the human brain. Proceedings of the National Academy of Sciences, 2014. 111(2): p. 823-828.
119. Raznahan, A., et al., Longitudinally mapping the influence of sex and androgen signaling on the dynamics of human cortical maturation in adolescence. Proceedings of the National Academy of Sciences of the United States of America, 2010. 107(39): p. 16988-93.
120. Lenz, K.M., et al., Microglia are essential to masculinization of brain and behavior. The Journal of Neuroscience, 2013. 33(7): p. 2761-2772.
121. Kang, H.J., et al., Spatio-temporal transcriptome of the human brain. Nature, 2011. 478(7370): p. 483-489.
122. Goldstein, J.M., R.J. Handa, and S.A. Tobet, Disruption of Fetal Hormonal Programming (Prenatal Stress) Implicates Shared Risk for Sex Differences in Depression and Cardiovascular Disease. Frontiers in Neuroendocrinology, 2013. 35(1): p. 140-158.
123. Nguyen, T.-V., et al., Testosterone-related cortical maturation across childhood and adolescence. Cerebral Cortex, 2013. 23(6): p. 1424-1432.
124. Chung, W.C., et al., Progestin receptor expression in the developing rat brain depends upon activation of estrogen receptor alpha and not estrogen receptor beta. Brain Research: Molecular Brain Research, 2006. 1082(1): p. 50-60.
125. Gorski, R.A., Sexual differentiation of the nervous system, in Principles of Neural Science, E.R. Kandel, J.H. Schwartz, and T.M. Jessell, Editors. 2000, McGraw-Hill Health Professions Division: New York. p. 1131-1146.
126. McEwen, B.S., Gonadal steroid influences on brain development and sexual differentiation, in Reproductive Physiology IV, R. Greep, Editor. 1983, University Park: Baltimore. p. 99-145.
127. O'Keefe, J.A., et al., Estrogen receptor mRNA alterations in the developing rat hippocampus. Brain Research. Molecular Brain Research, 1995. 30(1): p. 115-24.
128. Park, J.-J., et al., Neurogenesis and cell migration into the sexually dimorphic preoptic area/anterior hypothalamus of the fetal ferret. Journal of Neurobiology, 1996. 30(3): p. 315-28.
129. Simerly, R.B., et al., Distribution of androgen and estrogen receptor mRNA-containing cells in the rat brain: An in situ hybridization study. Journal of Comparative Neurology, 1990. 294(1): p. 76-95.
130. Tobet, S., et al., Brain sex differences and hormone influences: a moving experience? Journal of Neuroendocrinology, 2009. 21(4): p. 387-92.
131. Tobet, S.A., M.E. Basham, and M.J. Baum, Estrogen receptor immunoreactive neurons in the fetal ferret forebrain. Brain Research. Developmental Brain Research, 1993. 72(2): p. 167-80.
132. Takahashi, A., et al., Effects of ventromedial hypothalamic stimulation on glucose transport system in rat tissues. American Journal of Physiology, 1992. 263(6 Pt 2): p. R1228-34.
133. Vallee, M., et al., Prenatal stress induces high anxiety and postnatal handling induces low anxiety in adult offspring: correlation with stress-induced corticosterone secretion. Journal of Neuroscience, 1997. 17(7): p. 2626-36.
134. Weinstock, M., Does prenatal stress impair coping and regulation of hypothalamicpituitary- adrenal axis? Neuroscience and Biobehavioral Reviews, 1997. 21(1): p. 1-10.
135. Weinstock, M., et al., Prenatal stress selectively alters the reactivity of the hypothalamicpituitary adrenal system in the female rat. Brain Research: Molecular Brain Research, 1992. 595(2): p. 195-200.
136. Matsumoto, A. and Y. Arai, Sexual differentiation of neuronal circuitry in the neuroendocrine hypothalamus. Biomedical Review, 1997. 7: p. 5-15.
137. Barker, D.J., Intrauterine programming of adult disease. Molecular Medicine Today, 1995. 1(9): p. 418-23.
138. Henry, C., et al., Prenatal stress increases the hypothalamo-pituitary-adrenal axis response in young and adult rats. Journal of Neuroendocrinology, 1994. 6(3): p. 341-5.
139. Seckl, J.R., Glucocorticoid programming of the fetus; adult phenotypes and molecular mechanisms. Molecular and Cellular Endocrinology, 2001. 185(1-2): p. 61-71.
140. Majdic, G. and S. Tobet, Cooperation of sex chromosomal genes and endocrine influences for hypothalamic sexual differentiation. Frontiers in Neuroendocrinology, 2011. 32(2): p. 137-45.
141. Zuloaga, D.G., et al., Dexamethasone induces apoptosis in the developing rat amygdala in an age-, region-, and sex-specific manner. Neuroscience, 2011. 199: p. 535-47.
142. Carbone, D.L., et al., Prenatal Dexamethasone Exposure Potentiates Diet-Induced Hepatosteatosis and Decreases Plasma IGF-I in a Sex-Specific Fashion. Endocrinology, 2012. 153: p. 295-306.
143. Mueller, B.R. and T.L. Bale, Sex-specific programming of offspring emotionality after stress early in pregnancy. The Journal of Neuroscience, 2008. 28(36): p. 9055-9065.
144. Howerton, C.L., et al., O-GlcNAc transferase (OGT) as a placental biomarker of maternal stress and reprogramming of CNS gene transcription in development. Proceedings of the National Academy of Sciences, 2013. 110(13): p. 5169-5174.
145. Montano, M.M., M.H. Wang, and F.S. vom Saal, Sex differences in plasma corticosterone in mouse fetuses are mediated by differential placental transport from the mother and eliminated by maternal adrenalectomy or stress. Journal of Reproduction and Fertility, 1993. 99(2): p. 283-90.
146. Fameli, M., E. Kitraki, and F. Stylianopoulou, Effects of hyperactivity of the maternal hypothalamic-pituitary-adrenal (HPA) axis during pregnancy on the development of the HPA axis and brain monoamines of the offspring. International Journal of Developmental Neuroscience, 1994. 12(7): p. 651-9.
147. Alonso, S.J., C. Damas, and E. Navarro, Behavioral despair in mice after prenatal stress. Journal of Physiology and Biochemistry, 2000. 56(2): p. 77-82.
148. McCormick, C.M., et al., Sex-specific effects of prenatal stress on hypothalamicpituitary- adrenal responses to stress and brain glucocorticoid receptor density in adult rats. Brain Research. Developmental Brain Research, 1995. 84(1): p. 55-61.
149. Regan, J., et al., Latinos and their mental health. Tennessee Medicine, 2004. 97(5): p. 218-9.
150. Rhodes, M.E. and R.T. Rubin, Functional sex differences ('sexual diergism') of central nervous system cholinergic systems, vasopressin, and hypothalamic-pituitary-adrenal axis activity in mammals: A selective review. Brain Research. Brain Research Reviews, 1999. 30(2): p. 135-52.
151. McClellan, K.M., M.S. Stratton, and S.A. Tobet, Roles for gamma-aminobutyric acid in the development of the paraventricular nucleus of the hypothalamus. Journal of Comparative Neurology, 2010. 518(14): p. 2710-28.
152. Stratton, M.S., B.T. Searcy, and S.A. Tobet, GABA regulates corticotropin releasing hormone levels in the paraventricular nucleus of the hypothalamus in newborn mice. Physiology and Behavior, 2011. 104(2): p. 327-33.
153. Janssen, J., et al., Hippocampal changes and white matter lesions in early-onset depression. Biological Psychiatry, 2004. 56(11): p. 825-31.
154. Vakili, K., et al., Hippocampal volume in primary unipolar major depression: a magnetic resonance imaging study. Biological Psychiatry, 2000. 47(12): p. 1087-90.
155. Weniger, G., C. Lange, and E. Irle, Abnormal size of the amygdala predicts impaired emotional memory in major depressive disorder. Journal of Affective Disorders, 2006. 94(1-3): p. 219-29.
156. Goldstein, J.M., et al., Sex-Specific Impact of Maternal-Fetal Risk Factors on Depression and Cardiovascular Risk 40 Years Later. J Dev Orig Health Dis, 2011. 6(2): p. 353-364.
157. Clayton, J.A. and F.S. Collins, NIH to balance sex in cell and animal studies. Nature, 2014. 509(7500): p. 282-3.